PDS Biotech raises $22.55M in PIPE led by NantWorks founder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. KNX
10. ELV

Go back to PDS Biotech raises $22.55M in PIPE led by NantWorks founder

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

September 8, 2026 8:30 AM EDT

Dr. Soon-Shiong will Join PDS Biotechs Board of Directors

PDS Biotech Plans to Progress Development of PDS0301 Immunocytokine in Solid Tumors

PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today announced it has raised up to $22.55 million in equity funding in a Private Investment in Public Equity (PIPE) transaction. The round was led by Nant Capital, LLC (Nant) with additional participation by... More